rs895819
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Pre-miR-27a rs895819 polymorphism and risk of diffuse large B-cell lymphoma.
|
31797450 |
2020 |
rs387907272
|
|
|
0.070 |
GeneticVariation |
BEFREE |
High frequencies of the hotspot <i>MYD88</i>(L265P) mutation are observed in extranodal diffuse large B-cell lymphoma and Waldenström macroglobulinemia, thereby demonstrating this mutation's potential as a disease marker.
|
31699794 |
2019 |
rs3758391
|
|
|
0.010 |
GeneticVariation |
BEFREE |
SIRT1 rs3758391 polymorphism and risk of diffuse large B cell lymphoma in a Chinese population.
|
30377410 |
2018 |
rs1800797
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Additionally, rs1800797 was significantly association with breast cancer, non-Hodgkin's lymphoma, B-cell lymphoma and diffuse large B-cell lymphoma but not gastric cancer.
|
29552316 |
2018 |
rs2736098
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Association of MNS16A VNTR and hTERT rs2736098: G>A polymorphisms with susceptibility to diffuse large B-cell lymphoma.
|
28967095 |
2018 |
rs387907272
|
|
|
0.070 |
GeneticVariation |
BEFREE |
Lack of a Prognostic Impact of the MyD88 L265P Mutation for Diffuse Large B Cell Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.
|
28847710 |
2017 |
rs1178732315
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Lack of a Prognostic Impact of the MyD88 L265P Mutation for Diffuse Large B Cell Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.
|
28847710 |
2017 |
rs20551
|
|
|
0.010 |
GeneticVariation |
BEFREE |
EP300 single nucleotide polymorphism rs20551 correlates with prolonged overall survival in diffuse large B cell lymphoma patients treated with R-CHOP.
|
28725161 |
2017 |
rs387907272
|
|
|
0.070 |
GeneticVariation |
BEFREE |
Clinicopathologic significance of MYD88 L265P mutation in diffuse large B-cell lymphoma: a meta-analysis.
|
28496180 |
2017 |
rs1057520009
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Recent reports have shown molecular alterations in the gene encoding XPO1 and showed a mutation hotspot (E571K) in the following two hematological malignancies with similar phenotypes and natural histories: primary mediastinal diffuse large B cell lymphoma and classical Hodgkin's lymphoma.
|
28196522 |
2017 |
rs387907272
|
|
|
0.070 |
GeneticVariation |
BEFREE |
Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P-Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases.
|
27923841 |
2017 |
rs387907272
|
|
|
0.070 |
GeneticVariation |
BEFREE |
B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice.
|
27048211 |
2016 |
rs1390458638
|
|
|
0.010 |
GeneticVariation |
BEFREE |
B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice.
|
27048211 |
2016 |
rs7712513
|
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy.
|
26460308 |
2015 |
rs7765004
|
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy.
|
26460308 |
2015 |
rs387907272
|
|
|
0.070 |
GeneticVariation |
BEFREE |
Myd-88 L265P constitutive activating mutations are present in at least some cases of the diffuse large B-cell lymphoma form of vitreoretinal lymphoma.
|
25768255 |
2015 |
rs1800795
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Given the importance of understanding the genetic variations involved in the pathogenesis of non-Hodgkin's lymphoma (NHL), this pilot study was designed to investigate the impact of CD38 (184C/G; rs6449182) and IL-6 (-174 G/C; rs1800795) gene polymorphism on susceptibility of Egyptians to diffuse large B cell lymphoma (DLBCL); major types of NHL.
|
25564959 |
2015 |
rs6449182
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Given the importance of understanding the genetic variations involved in the pathogenesis of non-Hodgkin's lymphoma (NHL), this pilot study was designed to investigate the impact of CD38 (184C/G; rs6449182) and IL-6 (-174 G/C; rs1800795) gene polymorphism on susceptibility of Egyptians to diffuse large B cell lymphoma (DLBCL); major types of NHL.
|
25564959 |
2015 |
rs2910164
|
|
|
0.010 |
GeneticVariation |
BEFREE |
MicroRNA-146a rs2910164 polymorphism and the risk of diffuse large B cell lymphoma in the Chinese Han population.
|
25370733 |
2014 |
rs2070770
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The significance of single nucleotide polymorphism rs2070770 in CD20 gene in Chinese patients with diffuse large B-cell lymphoma.
|
24898664 |
2015 |
rs13181
|
|
|
0.010 |
GeneticVariation |
BEFREE |
A significant interaction with BMI was only observed for WRN (rs1801195; P = 0.004) for T-cell lymphoma and ERCC2 (rs13181; P = 0.002) for diffuse large B-cell lymphoma.
|
23619945 |
2013 |
rs1801195
|
|
|
0.010 |
GeneticVariation |
BEFREE |
A significant interaction with BMI was only observed for WRN (rs1801195; P = 0.004) for T-cell lymphoma and ERCC2 (rs13181; P = 0.002) for diffuse large B-cell lymphoma.
|
23619945 |
2013 |
rs387907272
|
|
|
0.070 |
GeneticVariation |
BEFREE |
MYD88 expression and L265P mutation in diffuse large B-cell lymphoma.
|
23380077 |
2013 |
rs1800890
|
|
|
0.020 |
GeneticVariation |
BEFREE |
The study found that polymorphism in interleukin 10 (IL10; rs1800890) modified the association between occupational exposure to organic solvents and the risk for diffuse large B-cell lymphoma (P(for interaction)=0.0058).
|
22609637 |
2013 |
rs113488022
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Mutations of the BRAF gene were identified in six (24%) diffuse large B-cell lymphomas (D594G in three germinal center diffuse large B-cell lymphomas, K601N in two germinal center diffuse large B-cell lymphomas, and V600E in one non-germinal center diffuse large B-cell lymphoma) and of the NRAS gene in two (8%) non-germinal center diffuse large B-cell lymphomas (Q61K and Q61H).
|
22575864 |
2012 |